News tagged with psychiatric drugs
Anabolic steroids may affect future mental health
There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg ...
Psychology & Psychiatry
May 20, 2013 |
3 / 5 (1) |
1
Sexual assaults in psych wards show urgent need for reform
Women admitted to psychiatry wards experience high levels of violence and sexual assaults, according to a report released this week by the Victorian Mental Illness Alliance Council.
Health
May 17, 2013 |
not rated yet |
0
Use of anti-epileptic drug during pregnancy associated with increased risk of autism
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study ...
Autism spectrum disorders
Apr 23, 2013 |
2 / 5 (1) |
0
|
Toxic protein build-up in blood shines light on Huntington's disease
A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today ...
Neuroscience
Sep 17, 2012 |
not rated yet |
0
|
Over-diagnosis and over-treatment of depression is common in the US
Americans are over-diagnosed and over-treated for depression, according to a new study conducted at the Johns Hopkins Bloomberg School of Public Health. The study examines adults with clinician-identified depression and individuals ...
Psychology & Psychiatry
Apr 30, 2013 |
1 / 5 (1) |
0
Study examines effects of genetic variants for infants with neonatal abstinence syndrome
Among infants with neonatal abstinence syndrome (NAS; caused by in utero opioid exposure), variants in certain genes were associated with a shorter length of hospital stay and less need for treatment, preliminary findings ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
not rated yet |
0
Researchers propose a new approach to understanding common psychiactric treatments
(Medical Xpress)—Drugs for psychiatric disorders such as depression and schizophrenia often require weeks to take full effect. "What takes so long?" has formed one of psychiatry's most stubborn mysteries. ...
Psychology & Psychiatry
Nov 21, 2012 |
5 / 5 (3) |
2
|
Brazilian mediums shed light on brain activity during a trance state
Researchers at Thomas Jefferson University and the University of Sao Paulo in Brazil analyzed the cerebral blood flow (CBF) of Brazilian mediums during the practice of psychography, described as a form of writing whereby ...
Neuroscience
Nov 16, 2012 |
4.3 / 5 (13) |
2
|
Researchers reveal more effective way of testing therapies to treat depression
(Medical Xpress)—Researchers have found a new method for studying depression in rats that mirrors an aspect of the mood-related symptoms of the condition in humans. Until now, the lack of animal models ...
Psychology & Psychiatry
Apr 19, 2013 |
5 / 5 (1) |
0
|
Cognitive behavioral therapy adds no value to drug treatment for opioid dependence
(Medical Xpress)—In a surprise finding, Yale researchers report that adding cognitive behavioral therapy to the most commonly used drug treatment for opioid dependence does not further reduce illicit drug ...
Psychology & Psychiatry
Jan 04, 2013 |
5 / 5 (1) |
0
|
Report: Mental illness struck 1 in 5 US adults in 2010
One in five adults in the U.S. had a mental illness in 2010, with people ages 18 to 25 having the highest rates, according to a national survey.
Psychology & Psychiatry
Jan 20, 2012 |
5 / 5 (3) |
0
Research reveals Huntington's hope
(Medical Xpress)—Researchers in Scotland and Germany have discovered a molecular mechanism that shows promise for developing a cure for Huntington's Disease (HD).
Neuroscience
Feb 27, 2013 |
3 / 5 (1) |
0
|
Non-drug ADHD treatments don't pan out in study
(HealthDay)—Many parents pursue costly and time-consuming treatments to help their children with attention-deficit/hyperactivity disorder. Now, a new study finds little evidence that non-drug interventions ...
Attention deficit disorders
Jan 30, 2013 |
5 / 5 (1) |
0
|
FDA warns consumers of dangers of the stimulant DMAA
(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...
Health
Apr 15, 2013 |
5 / 5 (2) |
0
Cannabinoid 2 receptors regulate impulsive behavior
A new study lead by the Neuroscience Institute of Alicante reveals how manipulating the endocannabinoid system can modulate high levels of impulsivity. This is the main problem in psychiatric illnesses such ...
Psychology & Psychiatry
Mar 08, 2012 |
4 / 5 (4) |
0